SUMMARY Proximal renal tubular function was studied in 522 consecutive patients entered into the Medical Research Council's fourth myelomatosis trial. Assessment was made at presentation after a 48 h period of hydration but before administration of chemotherapy. The most common abnormalities in the urine other than light chain proteinuria were raised concentrations of the low molecular weight proteins a,-microglobulin and a,-acid glycoprotein. These were usually accompanied by increases in urinary,lf-N-acetyl-D-glucosaminidase concentrations. The concentration of these substances in the urine directly correlated with urinary free light chain output. This tubular proteinuria was seen whether or not patients had impaired glomerular function, as assessed by a rise in serum creatinine concentration. Urinary concentrations of retinol binding protein, however, were generally increased only when serum creatinine concentrations were raised. This applied even when there were high concentrations of light chains, a,-microglobulin, a,-acid glycoprotein, and ,8-N-acetyl-D-glucosaminidase in the urine.
of these substances in the urine directly correlated with urinary free light chain output. This tubular proteinuria was seen whether or not patients had impaired glomerular function, as assessed by a rise in serum creatinine concentration. Urinary concentrations of retinol binding protein, however, were generally increased only when serum creatinine concentrations were raised. This applied even when there were high concentrations of light chains, a,-microglobulin, a,-acid glycoprotein, and ,8-N-acetyl-D-glucosaminidase in the urine.
There is therefore a selective tubular proteinuria in myelomatosis which is seen in almost all patients with urinary light chain values > 1 u/l. This proteinuria is generally reversible, when light chains no longer appear in the urine. Patients whose serum creatinine was >200 ,umol/l, however, had increased urinary output of retinol binding protein in addition to increased excretion of a,-microglobulin, a,-acid glycoprotein, and ,3-N-acetyl-D-glucosaminidase. Tubular proteinuria in many of these patients presenting in renal failure persisted even when light chain output was reduced after chemotherapy.
The aetiology of the renal failure in myelomatosis is not fully understood, but the evidence points towards multifactorial causes. In most cases the excretion of light chains in the urine appears to be an essential factor. Nevertheless, many patients excrete large amounts of light chains without any impairment of glomerular filtration rate. ' 2 There are several reports of varying degrees of defective reabsorption of low molecular weight proteins by the proximal tubular cells in myelomatosis, as detected by sodium dodecyl sulphate (SDS) polyacrylamide gel electrophoresis of urine34 or measurement of one or more low molecular weight proteins in the Accepted for publication 24 April 1984 urine.56 There are accounts of rare cases of Fanconi's syndrome occurring in myelomatosis, which indicate that occasionally severe irreversible global tubular damage can occur.78 It is difficult to infer from these studies the probable extent of proximal tubular dysfunction in myelomatosis and its relation to glomerular function for the estimates are influenced by the analytes chosen as indices of disease. Also there are technical problems in determining the total protein load applied to SDS polyacrylamide gels.
This paper analyses the ability of the kidney to reabsorb low molecular weight proteins from the glomerular filtrate in 522 untreated patients admitted to the Medical-Research Council ' Urine f8-N-acetyl-D-glucosaminidase was measured by a fluorimetric method using a 4-methylumbelliferone substrate as described elsewhere'415; 1 unit of f8-N-acetyl-D-glucosaminidase activity is that which will release 1 nmol of substrate/h/mmol urine creatinine. Twelve units was taken as the upper limit of normal. The 4-methylumbelliferone substrate was bought from Koch-Light Laboratories, Colnbrook, Berks. 
Results
Throughout the study arbitrary groups were used for convenience when comparing different degrees of renal involvement in myelomatosis. Three arbitrarily defined subsets were created with respect to serum creatinine to take into account the effects of impaired glomerular filtration: (1) patients with a serum creatinine < 130 Amol/1; (2) those with a small rise of serum creatinine 130-199 amol/l; (3) those with a serum creatinine ¢2O0 0,umoVI. A serum creatinine concentration of 200 umoVlI was chosen as a cut off value because survival rates of patients with values above and below this value differed considerably. A detailed analysis of the level of serum creatinine and light chain excretion in patients with creatinine >200 umolIl has been presented elsewhere.9 Three subsets were also made for light chain excretion: (a) <0 04 u/g Cr (this is the 95th percentile for polyclonal K light chain excretion in healthy subjects for this laboratory); (b) 0.04-1.0 u/g Cr, and (c) >1*0 u/g Cr. The division between (b) and (c) was chosen arbitrarily after inspection of the distribution of the data.
RELATION OF URINARY LIGHT CHAIN CONCENTRATION AND TYPE TO RENAL FAILURE
The distribution of serum creatinine and light chain excretion after hydration but before chemotherapy in 522 patients with myelomatosis is shown in Table   1 . The probability of the patients presenting with renal impairment (serum creatinine >200 gmol/l after correction of possible dehydration) was 0 34 when the urinary light chain excretion was >1 u/g Cr. By contrast, the probability was only 0-023 when the excretion was <0 04 u/g Cr. A raised serum creatinine concentration occurred as frequently in patients with K light chain proteinuria as in those with X light chain proteinuria ( The relation between the concentrations of free light chain and a,-microglobulin in urine of patients with both normal and raised serum creatinine concentrations is shown in Fig. 1 compared with patients with equivalent levels of light chain output with normal serum creatinine (Table 5 ).
a,-acid glycoprotein (MW 41 kda, peptide content 58%, pI 2 7)
The excretion of al-acid glycoprotein in the urine (Fig. 2) showed a similar correlation with the concentration of free light chains to that seen with a, microglobulin ( Table 3 ). In patients excreting light chains at a concentration of >1 ,ug/g Cr no secondary effect of renal failure was seen ( Fig. 2 and Table 5 ). Patients with high serum concentrations of a,-acid glycoprotein (>2-0 g/l), however, tended to show higher urinary al-acid glycoprotein excretions (Fig. 2) . For abbreviations see Table 4 . able concentrations, even where there was increased free light chain excretion, provided that the glomerular filtration was normal (Fig. 3 , Table 3 ). There was, however, a pronounced accentuation of retinol binding protein excretion in patients with raised serum creatinine concentrations (Fig. 3 , Table 4 rise when light chains were present in the urine (Fig.  4 , Table 4 ). Urinary values were not augmented further in those patients with increased serum creatinine concentrations (Table 5 ).
Discussion
The relation of light chain excretion and renal failure is discussed elsewhere '6-'9 and 
to change than tests of distal tubular function. In 60 cases of myelomatosis investigated by Virella et al4 using SDS polyacrylamide gel electrophoresis all patients with predominantly tubular proteinuria were also excreting light chains.
In this study almost every patient with monoclonal free light chain excretion (392/399; 98.2%) had impaired reabsorption of a,-microglobulin and a,-acid glycoprotein, and this was generally accompanied by increased /3-N-acetyl-D-glucosaminidase activity in the urine.
There 
